GNS to Provide CombinatoRx with Modeling Software for Drug Studies | GenomeWeb
NEW YORK (GenomeWeb News) - Gene Network Sciences will use its biological modeling software to assist CombinatoRx in drug efficacy and safety studies, GNS said last week.
Under the agreement, the companies will use GNS' reverse engineering/forward simulation software, which it calls REFSTM, to characterize the cellular mechanisms that can cause “synergistic interactions” between multi-target candidate drugs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.